• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number 0033555702
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Cardiac Perforation (2513); Pericardial Effusion (3271)
Date of Event 06/06/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a perforation, pericardial effusion (pe) and cardiac tamponade occurred; procedure was cancelled.During a watchman left atrial appendage closure (laac) procedure, a versacross connect access solution kit was selected for use.The physician was able to successfully cross the interatrial septum (ias) with the versacross rf pigtail wire with no issues (inferior and mid/posterior).However, since the patients ias was thick, it caused the versacross dilator and watchman sheath to get hung up.In an attempt to cross and dilate it, the physician increased his forward pressure on the ias with the devices, and they both suddenly and unexpectedly advanced through the ias, which lead to the dilator went too far into the left atrium (la) and perforated the posterior wall of the la.The tip of the versacross rf wire was protruding out of the dilator at this time.A pericardial effusion was immediately noticed via transesophageal echocardiogram (tee), and the patient's blood pressure dropped significantly, indicating a cardiac tamponade.The procedure was then cancelled.Therefore, a cardiothoracic (ct) surgeon was immediately notified, and heparin was reversed.The physician attempted a pericardiocentesis but struggled to get the equipment into the pericardial space.The patient vitals were being maintained with medication while the physician continued to navigate into the pericardial space.By the time a drain was properly placed, the pericardial space had thrombosed enough to significantly slow the bleeding from the perforation and the patient's hemodynamics started to stabilize without the use of extra medication.Due to the blood in the pericardial space being mostly clotted, not much fluid/blood was able to drain.At this time, the physician and ct surgeon discussed the options and ultimately decided the patient did not require surgical intervention seeing as they were stable and the blood in the pericardial space was thrombosed.The patient was then sent to the surgical intensive care unit (sicu) while still intubated and with the drain remaining in place.The pe occurred at 10:15am, at approximately 3:30pm the physician stated that they were doing well, and they were planning to extubate later.The patient was discharged on (b)(6) 2024.The device is not expected to be returned for analysis (disposed).Prior to the procedure, there was evidence of a baseline pe on tee.The patient was not on warfarin or any antiplatelet drugs at the time of procedure.A non-boston scientific introducer was used to gain femoral access.No other issues were reported.
 
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.A separate problem report will be filed for the versacross dilator.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2775 matheson blvd east
mississauga, on L4W 4 P7
CA   L4W 4P7
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key19610174
Report Number2124215-2024-38923
Device Sequence Number12783627
Product Code DXF
UDI-Device Identifier00685447012597
UDI-Public00685447012597
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K150709
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Lot Number0033555702
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/06/2024
Initial Report FDA Received Date06/25/2024
Date Device Manufactured02/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization; Life Threatening;
Patient Age85 YR
Patient SexFemale
Patient Weight50 KG
-
-